Shots:In the year 2022, Amgen was the top dealmaker, based on the total deal value, with 6 deals at a total announced value of ~$34.5B. Amgen has disclosed 5 out of the 6 deals leaving its BigHat Biosciences deal undisclosed Amgen’s acquisition of Horizon Therapeutics for a value of ~$28.3B was the key contributor…
